These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3839943)

  • 1. Association of factor V activity with membranous vesicles released from human platelets: requirement for platelet stimulation.
    Bode AP; Sandberg H; Dombrose FA; Lentz BR
    Thromb Res; 1985 Jul; 39(1):49-61. PubMed ID: 3839943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of coagulant activity in human platelets: release of membranous vesicles providing platelet factor 1 and platelet factor 3.
    Sandberg H; Bode AP; Dombrose FA; Hoechli M; Lentz BR
    Thromb Res; 1985 Jul; 39(1):63-79. PubMed ID: 3839944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of factor V-like coagulant activity from catalytic phospholipid-like surface activity in membrane fractions derived from human platelets.
    Dombrose FA; Bode AP; Lentz BR
    Thromb Res; 1981 Jun 1-25; 22(5-6):603-21. PubMed ID: 6895424
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for appearance of "lysis independent" procoagulant activities in collagen or thrombin stimulated platelets.
    Brox JH; Osterud B
    Thromb Res; 1983 Jun; 30(5):449-58. PubMed ID: 6612678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of platelet factor 3 in platelet concentrates stored for transfusion.
    Bode AP; Miller DT
    Vox Sang; 1986; 51(4):299-305. PubMed ID: 3798864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The platelet membrane as a catalytic surface in thrombin generation: availability of platelet factor 1 and platelet factor 3.
    Bode AP; Dombrose FA; Lentz BR; Roberts HR
    Ann N Y Acad Sci; 1981; 370():348-58. PubMed ID: 6943964
    [No Abstract]   [Full Text] [Related]  

  • 7. [Present-day views on the role of blood platelets in hemostasis. II. Role of platelets in plasma clotting].
    Dmoszyńska-Giannopoluou A; Kowalewski J
    Pol Arch Med Wewn; 1978 Aug; 60(2):175-8. PubMed ID: 362384
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.
    Johnstone IB
    Can J Comp Med; 1983 Apr; 47(2):172-9. PubMed ID: 6883184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.
    Miletich JP; Majerus DW; Majerus PW
    J Clin Invest; 1978 Oct; 62(4):824-31. PubMed ID: 701480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of platelet factor V in prothrombin conversion.
    Chesney CM; Pifer DD; Colman RW
    Thromb Res; 1983 Jan; 29(1):75-84. PubMed ID: 6836546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal formation of the prothrombinase complex: factor V deficiency and related disorders.
    Tracy PB; Mann KG
    Hum Pathol; 1987 Feb; 18(2):162-9. PubMed ID: 3804320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet procoagulant properties studied with snake venom prothrombin activators.
    Speijer H; Govers-Riemslag JW; Zwaal RF; Rosing J
    Thromb Haemost; 1987 Jun; 57(3):349-55. PubMed ID: 3310319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of the platelet factor V content to platelet factor 3 activity.
    van Zutphen H; Bevers EM; Hemker HC; Zwaal RF
    Br J Haematol; 1980 May; 45(1):121-31. PubMed ID: 7189664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet factor 3 assay and the availability of platelet factor 3 in collagen or thrombin stimulated platelets.
    Brox JH; Osterud B
    Thromb Res; 1984 Mar; 33(5):555. PubMed ID: 6719401
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of coagulation factor V by a platelet protease.
    Kane WH; Mruk JS; Majerus PW
    J Clin Invest; 1982 Nov; 70(5):1092-100. PubMed ID: 6752201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet membrane involvement in blood coagulation.
    Hemker HC; van Rijn JL; Rosing J; van Dieijen G; Bevers EM; Zwaal RF
    Blood Cells; 1983; 9(2):303-17. PubMed ID: 6661560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder.
    Miletich JP; Kane WH; Hofmann SL; Stanford N; Majerus PW
    Blood; 1979 Nov; 54(5):1015-22. PubMed ID: 497393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The localization of factor V within normal human platelets and the demonstration of a platelet-factor V antigen in congenital factor V deficiency.
    Breederveld K; Giddings JC; ten Cate JW; Bloom AL
    Br J Haematol; 1975 Mar; 29(3):405-12. PubMed ID: 1103945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of clotting factors associated with blood platelets after gel filtration.
    Tangen O; Lestrup EB; Berman HJ
    Thromb Diath Haemorrh; 1973 Nov; 30(2):289-98. PubMed ID: 4773368
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulation factor activity in platelet concentrates.
    Simon TL; Henderson R
    Transfusion; 1979; 19(2):186-9. PubMed ID: 432931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.